Lifesciences
RSLS ReShape Lifesciences Global Weight-Loss Leader | $ TargetOn 6/17/2021 Alliance Global Partners brokerage Boosted the Price Target for RSLS ReShape Lifesciences stock from $12.00 to $18.50!
ReShape Lifesciences is America's premier weight-loss solutions company.
The FDA-approved Lap-Band® program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy.
The ReShape Vest™ System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. Reshapecare™ virtual health coaching program is a virtual telehealth weight management program that supports lifestyle changes for all weight-loss patients, to help them keep the weight off over time. (accesswire.com)
My price target is 12usd short term.
Oversold, may reverse soonAfter some price downgrades and an offering priced at $41, the stock saw some aggressive selling and a recent bottom may be in. Keep on watch, not quite bullish on it yet.
MJ Trending UpETFMG Alternative Harvest (NYSE: MJ )
What is ETFMG Alternative Harvest?
An ETF that acceptance of various uses of the cannabis plant such as pharmaceuticals, biotechnology and life sciences,
JesusTrade Score:
Buy
Scale Score:
Low (3/10)
Portfolio Hold:
Yearly Hold
Fundamental Reasoning:
The following below are the top 10 holding for MJ:
GW Pharmaceuticals PLC Sponsored ADR (GWPH) Aphria Inc (APHA) Aurora Cannabis Inc. (ACB) MediPharm Labs Corp. (MEDIF)
Cronos Group Inc (CRON) Corbus Pharmaceuticals Holdings Inc (CRBP) OrganiGram Holdings Inc (OGI)
Canopy Growth Corporation (CGC) Tilray, Inc. (TLRY) Swedish Match AB (SWMAF)
All of these but Tilray and Swedish Match have bullish diverange and have broke out. Tilray could just follow the hype of the other stocks and Swedish Match has been having an up trend since March of 2009 and has about $30 more to run. With mojirty of these stocks being worth less than $10 or even $5. I don't see why the volume wouldn't be coming in. On google trends there an increase of cannabis and cannabis companies being searched. which gives me a idea that new buyers could be coming.
Insto Accumulation & Rejection ZoneTechnicals
Price encroaching on 0.46, a long established Multi Year Rejection Zone
Target 0.76, also a well established reversion point
CoT
Volumes show on-going strong accumulation in buy ups and absorbing supply
Fundamentals
VERY STRONG for an ASX micro
Tapping on cash flow positive, diversified revenue streams, STRONG YOY revenue growth and recent move into the USA market